China Top Companies List by Market Cap in January 2024

China Top Companies List by Market Cap as of Jan-05-2024. Biggest China Companies List by Market Cap in 2024. China Largest Companies in 2024.

China Top Companies in 2024

Total Market Cap of China Top 500 Companies is 8.94 Trillion USD as of Jan-05-2024.

China Top Companies by Market Cap in 2024, China Largest Companies in 2024, China Biggest Companies by Market Cap.

Xuan Wu Cloud Technology Holdings Limited

Rank as per Search Criteria: 5201

World Rank (Jan-2024): 18,507

Market Cap (Jan-05-2024): 0.18 Billion USD

World Rank (Jul-30-2023): 18,148

Market Cap (Jul-30-2023): 0.20 Billion USD

Headquarters Country: China

Company Website: XUAN WU CLOUD TECHNOLOGY HOLDINGS LIMITED

China New City Commercial Development

Rank as per Search Criteria: 5202

World Rank (Jan-2024): 18,514

Market Cap (Jan-05-2024): 0.18 Billion USD

World Rank (Jul-30-2023): 16,960

Market Cap (Jul-30-2023): 0.25 Billion USD

World Rank (Jan-07-2022): 17,873

Market Cap (Jan-07-2022): 0.25 Billion USD

Headquarters Country: China

Business Sector: Real Estate

Stock Price: Yahoo @ HongKong

Company Website: CHINA NEW CITY COMMERCIAL DEVELOPMENT

Poten Environment Group

Rank as per Search Criteria: 5203

World Rank (Jan-2024): 18,519

Market Cap (Jan-05-2024): 0.18 Billion USD

World Rank (Jul-30-2023): 13,520

Market Cap (Jul-30-2023): 0.44 Billion USD

World Rank (Jan-07-2022): 14,059

Market Cap (Jan-07-2022): 0.46 Billion USD

Headquarters Country: China

Business Sector: Waste and Trash Management

Stock Price: Yahoo @ Shanghai

Company Website: POTEN ENVIRONMENT GROUP

I-MAB

Rank as per Search Criteria: 5204

World Rank (Jan-2024): 18,548

Market Cap (Jan-05-2024): 0.18 Billion USD

World Rank (Jul-30-2023): 17,107

Market Cap (Jul-30-2023): 0.24 Billion USD

World Rank (Jan-07-2022): 4,633

Market Cap (Jan-07-2022): 3.18 Billion USD

Headquarters Country: China

Business Sector: Healthcare, Biopharmaceutical, Biotechnology

Annual Revenue in USD: 13 Million USD

Annual Net Income in USD: -339 Million USD

Annual Results for Period Ending: Dec-2021 ending year

Employee Count: 228

Employee Count as of Date: As on 2020

Company Profile:

I-Mab is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company annual revenue is 114.5 million USD. The headquarters is in China.

Stock Price: Yahoo @ Nasdaq

Company Website: I-MAB